Professor Susan Clarke

Professor Susan Clarke

Clinical Associate Professor, Clinical Medicine


Publications and Further Research Outputs

  • Sadlier C, Rowley D, Morley D, Surah S, O'Dea S, Delamere S, O'Leary J, Smyth P, Clarke S, Sheils O, Bergin C, Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act., HIV medicine, 15, (8), 2014, p499-504Journal Article, 2014, DOI , TARA - Full Text
  • Sadlier, C., Lynam, A., O'Dea, S., Delamere, S., Quinlan, M., Clarke, S., Sheils, O., Bergin, C., HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland, Human Vaccines and Immunotherapeutics, 12, (6), 2016, p1536-1541Journal Article, 2016
  • Hennessy,M.; Clarke,S.; Spiers,J.P.; Mulcahy,F.; Kelleher,D.; Meadon,E.; Maher,B.; Bergin,C.; Tjia,J.; Hoggard,P.; Back,D.; Barry,M., Intracellular indinavir pharmacokinetics in HIV infected patients: comparison with plasma pharmacokinetics, Antiviral Therapy, 8, 2003, p191 - 198Journal Article, 2003
  • Hennessy,M.; Clarke,S.; Spiers,J.P.; Kelleher,D.; Mulcahy,F.; Hoggard,P.; Back,D.; Barry,M., Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV infected patients, Antiviral Therapy, 9, 2004, p115 - 122Journal Article, 2004
  • Igoe D, Kelleher M, Cooney F, Clarke S, Quinlan M, Lyons F, Fitzgerald M, Crowley B, There has been a true rise in Neisseria gonorrhoeae but not in Chlamydia trachomatis in men who have sex with men in Dublin, Ireland., Sexually transmitted infections, 2014Journal Article, 2014
  • Rowley D, Houlihan L, McFaul K, Clarke S, Lyons F, A diagnostic dilemma: drug-induced aseptic meningitis in a 45-year-old HIV-positive man., International journal of STD & AIDS, 2013Journal Article, 2013
  • S Clarke, K Butler, C Bergin, F Lyons, G Sheehan, M Horgan, F Mulcahy, 'National guidelines for the active management of HIV in pregnancy. ', Irish medical journal 94 (5), 137-140, 2001, -Protocol or guideline, 2001
  • S. Clarke, P. Harrington, C. Condon, D. Kelleher, O. P. Smith and F. Mulcahy, Late onset hepatitis and prolonged deterioration in hepatic function associated with nevirapine therapy, International journal of STD & AIDS, 11, (5), 2000, p336-7Journal Article, 2000, URL
  • Clarke S, Merry C, Moran aM, Pneumococcal Pneumonia Associated With Perianal HSV Type 2 Infection In A HIV seropositive Patient, 11, J Eur Acad Dermatol Venerol, 1998, p257 - 258Report, 1998
  • Clarke S, Merry C, O'leary A, Ryan M, Aids To Compliance In HIV Positive Patients, Sixth National Scientific Meeting , RCPI, 1997Poster, 1997
  • Merry C, Ryan M, Clarke S, Courtney G, Mulcahy FM, Triple Therapy In HIV Positive Intravenous Drug users, Seventh National Scientific Medical Meeting , 1998Poster, 1998
  • Glynn, R.W., Byrne, N., O'Dea, S., Shanley, A., Codd, M., Keenan, E., Ward, M., Igoe, D., Clarke, S., Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland, International Journal of Drug Policy, 52, 2018, p9-15Journal Article, 2018, DOI
  • Van Hout M.C., Crowley D., O'Dea S., Clarke S., Chasing the rainbow: pleasure, sex-based sociality and consumerism in navigating and exiting the Irish Chemsex scene, Culture, Health and Sexuality, 21, (9), 2019, p1074 - 1086, p1074-1086Journal Article, 2019, DOI
  • Mulligan V., Lynagh Y., Clarke S., Unemo M., Crowley B., Prevalence, Macrolide Resistance, and Fluoroquinolone Resistance in Mycoplasma genitalium in Men Who Have Sex with Men Attending an Sexually Transmitted Disease Clinic in Dublin, Ireland in 2017-2018, Sexually Transmitted Diseases, 46, (4), 2019, pe35 - e37, pe35-e37Journal Article, 2019, DOI
  • George S., Bergin C., Clarke S., Courtney G., Codd M.B., Health-related quality of life and associated factors in people with HIV: An Irish cohort study, Health and Quality of Life Outcomes, 14, (1), 2016Journal Article, 2016, DOI
  • McFaul K., Rowley D., O'Reilly A., Clarke S., Access to post-exposure prophylaxis following sexual exposure for men who have sex with men in an Irish healthcare setting, International Journal of STD and AIDS, 26, (8), 2015, p521 - 525, p521-525Journal Article, 2015, DOI
  • O'Rourke S., O'Flaherty N., Coyne D., Lynam A., Clarke S., O'Dea S., Fitzpatrick S., Connell J., Crowley B., Seroprevalence of human herpesvirus 8 in Ireland among blood donors, men who have sex with men, and heterosexual genitourinary medicine and infectious diseases clinic attendees, Journal of Medical Virology, 2021Journal Article, 2021, DOI
  • Greig J.M., Wood C.G.A., Clarke S.U., 11 Special considerations in pregnancy, HIV Medicine, 12, (SUPPL. 2), 2011, p102 - 108, p102-108Journal Article, 2011, DOI
  • Clarke S.M., Mulcahy F.M., Tjia J., Reynolds H.E., Gibbons S.E., Barry M.G., Back D.J., Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users, Clinical Infectious Diseases, 33, (9), 2001, p1595 - 1597, p1595-1597Journal Article, 2001, DOI
  • Clarke S.,Mulcahy F., A review of recent advances in GenitoUrinary Medicine., Hospital Doctor, 1998, p37 - 44Journal Article, 1998
  • Clarke S., Mulcahy F., Use of Antiretroviral agents in the treatment of HIV infection, Irish Medical Journal, 1998Journal Article, 1998
  • Barry M., Clarke S., Mulcahy F., Back D., Hydroxyurea induced neurotoxicity in HIV disease, Hydroxyurea induced neurotoxicity in HIV disease, 13, (12), 1999, p1592 - 1594Journal Article, 1999
  • Clarke S., Mulcahy F., Directly Administered Antiretroviral Therapy (DAART) for the treatment of HIV infection in IDU's, HIV&AIDS, 5, (2), 1999, p8 - 10Journal Article, 1999
  • Clarke S., Harrington P., Barry M., Mulcahy F., The tolerability of Efavirenz post Nevirapine related adverse events, Clinical Infectious Diseases , 2000, p806 - 807Journal Article, 2000
  • Clarke S.M., Mulcahy F.M., Antiretroviral Therapy for injection drug users, Int Journal STD AIDS , 2000, p627 - 631Journal Article, 2000
  • Clarke S., Mulcahy F., Healy M., Condon S., Butler K, The efficacy and tolerability of combination antiretroviral therapy in pregnancy :infant and maternal outcome., Int Journal STD AIDS , 2000, p220 - 223Journal Article, 2000
  • Clarke S., Mulcahy F., Efavirenz Therapy in Drug Users, 2000, p15 - 19Journal Article, 2000
  • Kelly G.E., Clarke S., Has there been a turning point in the numbers of AIDS and HIV antibody positive cases in Ireland?, Ir J Med Sc , 2000, p183 - 187Journal Article, 2000
  • Susan M Clarke, Fiona M Mulcahy, John Tjia, Helen E Reynolds, , The Pharmacokinetics of Methadone in HIV Positive Patients Receiving the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz, Br J Clin Pharm , 2001, p213 - 218Journal Article, 2001
  • .Susan M Clarke, Fiona M Mulcahy, John Tjia, Bergin C., Boyle N., Helen E Reynolds, Michael G Barry and David J Back, Absence of Opioid Withdrawal Symptoms with Lopinavir/Ritonavir and methadone, 2002, p1143 - 1145Journal Article, 2002
  • Rowley D, Houlihan L, McFaul K, Clarke S, Lyons F, A diagnostic dilemma: Drug-induced aseptic meningitis in a 45-year-old HIV-positive man., Int J STD AIDS , 2014Journal Article, 2014
  • Dr. Kiran Santlal1, Dr. Fiona Fenton1,Adam Shanley2, Siobhan O'Dea2, Graham Ryall3, Dr. Susan Clarke5 , Dr. Margaret Fitzgerald6, Dr. Eamon Keenan7, A Collaborative Response to Chemsex & GHB Usage in Ireland, Lisbon Addictions Conference, Lisbon, 2019, 2019Poster, 2019
  • Louise Pomeroy GMHS, Mick Quinlan GMHS, Susan Clarke SJH / GMHS, A review of Gonorrhoea Contacts, SSSTDI, 2013Oral Presentation, 2013
  • A. Lynam, M. Quinlan, S. Clarke, L. Pomeroy, M. Kelleher, B. Crowley, F. Cooney, F. Lyons on behalf of the Gonorrhoea control group, Positive pharyngeal GC NAAT - what does it really mean?, SSSTDI, 2014Oral Presentation, 2014
  • Farrell, G.; Murphy, S.; Nagle, G. & Clarke, S., Audit and Review of Nurse-Led Clinic for newly diagnosed HIV+ Patients at the GUIDE Clinic, SSSTDI, 2017Oral Presentation, 2017
  • Siobhan O Dea, Susan Clarke, Point of Care Rapid HIV testing in a nurse led clinic, uptake and acceptability, SSSTDI, 2017Oral Presentation, 2017
  • Duggan P, O'Dea S, O'Sullivan C, Deane H, Clarke S, HPV Vaccine at Gay Men's Health Service (GMHS), SSSTDI, 2017Oral Presentation, 2017
  • Shay Keating, Susan Clarke, PrEP at the GMHS - one year on, SSSTDI, 2018Oral Presentation, 2018
  • Farrell, G.; Kelly, L.; Murphy, S.; Clarke, S., Rapid ART Initiation in Newly Diagnosed HIV Infection: An Audit from the GUIDE Clinic, SSSTDI, 2019Oral Presentation, 2019
  • S Clarke, OPAT - Are we there yet? Successful fulfillment of an OPAT service through a private provider, IDSI, 2013Oral Presentation, 2013
  • Louise Pomeroy1, Julia Enkelman1,2, Mick Quinlan1, Susie Clarke1,2 , Pharyngeal GC Is it NAAT time to change the management of GC Contacts ? , SSSTDI Galway, 2013Oral Presentation, 2013
  • Louise Pomeroy1, Julia Enkelman1,2, Mick Quinlan1, Susie Clarke1,2 , Pharyngeal GC Is it NAAT time to change the management of GC Contacts ? , SSSTDI Galway, 2014Oral Presentation, 2014
  • S Clarke, Successful Fulfilment of an OPAT service through a private providor, UK OPAT Initiative BSAC National Conference, 2013Oral Presentation, 2013
  • E. Sweeney1 , N. Curtin2 , E. de Barra3 , K. Burns4 , E. O'Neill5 , E. Feeney6 , H. Tuite7 , A. Jackson8 , P. Gavin9 , S. Clarke1 , S. O'Connell10, E. Muldoon2,11 ., National Guidelines on the Provision of Outpatient Parenteral Antimicrobial Therapy (OPAT), Irish medical Journal, 113, (7), 2019, p123-Journal Article, 2019
  • Clarke S.,Donnelly S.,Todd A.,Fraser A.,Casey E.B., Assessment of patient insight,compliance, and symptomatology in Ankylosing Spondylitis. , Irish Medical Journal , Irish Rheumatology Society, 1996, 54, (2), 1996, pp4-Poster, 1996
  • Merry C.,Clarke S.,O'Leary A.,Ryan M.,Mulcahy F., Improved drug compliance in HIV positive patients., AIDS, CROI, 10, (2), 1996, pp138-Poster, 1996
  • Clarke S., Courtney G., Ryan M., Broderick A.M., Butler K., Mulcahy F. , Maternal tolerability and efficacy of antiretroviral therapy in pregnancy., Irish Journal of Medical Science, National Scientific Meeting, 1999, 1999Poster, 1999
  • Clarke S., Merry C., Ryan M., Martin J., Mulcahy F., Clinical experience with Nevirapine, National Scientific Meeting, Dublin, 1999, 168, (3), 1999Poster, 1999
  • Clarke S., Ryan M., Merry C., Mulcahy F., Daily administration therapy in a cohort of intravenous drug users., Irish Journal of Medical Science, National Scientific Meeting, 168, (3), 1999Poster, 1999
  • A Profile of non-national patients attending a Dublin STD clinic., Clarke S., Mulcahy F.M., Irish Journal of Medical Science, National Scientific Meeting, 168, (3), 1999Poster, 1999
  • Coffey J., Landers D., Smith C., Clarke S., Mulcahy F., HIV infection and concomitant STD infection., Irish Journal of Medical Science, National Scientific Meeting, 154, (1), 1996Poster, 1996
  • Clarke S., Courtney G., Ryan M., Broderick AM., Butler K., Mulcahy F., Combination antiretroviral therapy in pregnancy:maternal tolerability and efficacy., HIV Medicine, BASSH 1999, Cardiff, 1999, 1, (1), 1999, pp50-Poster, 1999
  • Clarke S., Courtney G., Ryan M., Broderick AM., Butler K., Mulcahy F., Combination antiretroviral therapy in pregnancy:maternal tolerability and efficacy., HIV Medicine, MSSVD 1999, Wales LLandudno, 1999, 1, (1), 1999, pp50-Poster, 1999
  • Clarke S., Ryan M., Connolly S., Mulcahy F., Resolution of peripheral neuropathy with antiretroviral therapy., HIV Medicine, MSSVD 1999, LLandudno Wales, 1, (1), 1999, pp67-Poster, 1999
  • Clarke S., Harrington P., Forkin C., Curran S., Keenan E., Mulcahy F., DAART - for the treatment of injection drug users with HIV infection, Irish Journal of Medical Science, National Scientific Meeting, Dublin, 2000, 2, (1), 2000, pp32-Poster, 2000
  • Clarke S., Courtney G., Forkin C., Harrington P., Mulcahy F., Resolution of recalcitrant molluscum contagiosum with intravenous cidofovir., Irish Journal of Medical Science, National Scientific Meeting, Dublin, 2000, 2, (1), 2000, pp33-Poster, 2000
  • Clarke S., Forkin C., Bogan C., Courtney G., Mulcahy F. S., Forkin C., Bogan C., Courtney G., Mulcahy F., Sarcoidosis presenting with hypercalcaemia six months post HAART., Irish Journal of Medical Science, National Scientific Meeting, Dublin, 2000, 2, (1), 2000, pp36-Poster, 2000
  • Clarke S., Delamere S., O'Grady P., Coleman C., Mulcahy F., The effect of switching diagnostic tests for chlamydia trachomatis from tissue culture to ligase chain reaction., Irish Journal of Medical Science, National Scientific Meeting, Dublin, 2000, 2, (1), 2000, pp36-Poster, 2000
  • Clarke S., Mulcahy F., Barry M., Tjia J., Reynolds H., Gibbons S., Back D., Managing Managing methadone and NNRTI's: Guidelines for clinical practice. and NNRTI's: Guidelines for clinical practice., Irish Journal of Medical Science, National Scientific Meeting, Dublin, 2000, 1, 2000, pp37-Poster, 2000
  • Donnelly J., Clarke S., Keenan E., Mulcahy F., To assess the prevalence of Chlamydia Trachomatis in a cohort of women attending To assess the prevalence of Chlamydia Trachomatis in a cohort of women attending methadone prescribing clinics in Dublin. prescribing clinics in Dublin. , Irish Journal of Medical Science, National Scientific Meeting, Dublin, 2000, (1), 2000, pp37-Poster, 2000
  • Clarke S., Mulcahy F., Barry M., Tjia J., Reynolds H., Gibbons S., Back D., The effect of nevirapine on the pharmacokinetics of methadone., HIV Medicine, 6th Annual Conference of the HIV Association, Edinburgh, 2000, 1, 2000, pp2-Poster, 2000
  • Harrington P., Clarke S., Ryan M., Bergin C., Mulcahy F., Efficacy and Tolerability of Hydroxyurea containing salvage antiretroviral regimens in the management of HIV infection., AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 2000, 14, (4), 2000, ppS35-Poster, 2000
  • Harrington P., Clarke S., Ryan M., Bergin C., Mulcahy F., Efficacy and Tolerability of Hydroxyurea containing salvage antiretroviral regimens in the management of HIV infection., AIDS, 5th International Congress on Drug Therapy in HIV infection, Glasgow 2000, 14, (4), 2000, ppS35-Poster, 2000
  • Clarke S., Delamere S., Lyons F., Bergin C., Mulcahy F., Analysing limiting factors in the acceptance of HAART in IDU's, AIDS, 5th International Congress on Drug Therapy in HIV infection, Glasgow 2000, 14, (4), 2000, ppS45-Poster, 2000
  • McMahon C., Clarke S., Gaynor S., McGrath E., Mulcahy F., Bergin C., Cocaine induced Cocaine induced thrombocytopenia in a young HIV seropositive injecting drug user. in a young HIV seropositive injecting drug user., AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 14, (4), 2000, ppS67-Poster, 2000
  • Clarke S., Mulcahy F., Bergin C., Tjia J., Brown R., Barry M., Back DJ., The Pharmacokinetic interaction between nelfinavir and methadone., AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 2000, 14, (4), 2000, ppS95-Poster, 2000
  • Hennessy M., Clarke S., Mulcahy F., Bergin F., Tjia J., Back DJ., Barry M., Intracellular indinavir pharmacokinetics in HIV positive patients., AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 2000, 14, (4), 2000, ppS97-Poster, 2000
  • Coughlan S., Clarke S., Conroy A., Mulcahy F., Hall W.W., Bergin C., Clinical utility of HIV-1 genotypicClinical utility of HIV-1 genotypic drug resistance testing in a heterogenous non-trial populationdrug resistance testing in a heterogenous non-trial population, AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 14, (4), 2000, ppS116-Poster, 2000
  • Hopkins S., Rogers K., Clarke S., Lyons F., Mulcahy F., Bergin C., Hepatitis C: prevalence and implications for treatment in the HIV co-infected population., AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 2000, 14, (4), 2000, ppS125-Poster, 2000
  • McGrath E., Clarke S., McMahon C., Mulcahy F., Bergin C., Life-saving chemotherapy for Kaposi's Sarcoma in a HIV positive pregnant woman., AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 2000, 14, (4), 2000, ppS131-Poster, 2000
  • Ryan M., Clarke S., McCullagh L., Merry C., Barry M., Mulcahy F., Changing demographics of an Irish HIV infected cohort from 1995 to 1999, AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 2000, 14, (4), 2000, ppS137-Poster, 2000
  • Clarke S., Butler K., Bergin C., Sheehan G., Horgan M., Mulcahy F., The Active management of HIV in pregnancy., AIDS, 5th International Congress on Drug Therapy in HIV infection, , Glasgow 2000, 2000, 14, (4), 2000, ppS138-Poster, 2000
  • S Clarke P Harrington C Forkin S Curran E Keenan F Mulcahy, DAART - A 1 year review, HIV Medicine, 1, (3), 2001, p173 - 174Journal Article, 2001
  • C Sadlier, A Lynam, S O'Dea, S Delamere, M Quinlan, S Clarke, O Sheils, C Bergin, HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland, Human vaccines & immunotherapeutics, 6, (2), 2016, p1536 - 1541Journal Article, 2016
  • S Clarke, OPAT in Ireland - the first few years, National OPAT Conference (BSAC), London, 2015, 2015Oral Presentation, 2015
  • Cathal de Bruin, Noreen Curtin, Susan Clarke, Pharmacoeconomic evaluation of an OPAT Program in Ireland, IDSI , Dublin, 2016, 2016Poster, 2016
  • Clarke S, Delamere S, McCullagh L, Hoskins S, Bergin C, Mulcahy F, Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users, HIV Med, 4, (1), 2003, p33 - 37Journal Article, 2003, DOI
  • Clarke S., Mulcahy F., Whats new for IDUs with HIV infection?, Sex Trans Infect, 79, (2), 2003, p80 - 83Journal Article, 2003
  • Hopkins S, Lambourne J, Farrell G, McCullagh L, Hennessy M, Clarke S, Mulcahy F, Bergin C., Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals., HIV Med. , 7, (4), 2006, p248-54.Journal Article, 2006, DOI , URL
  • Nelson M, Dockrell D, Edwards S, Angus B, Barton S, Beeching N, Bergin C, Boffito M, Breen R, Cartledge J, Clarke S, Fisher M, Freedman A, Gazzard B, Grant A, Greig J, Jones R, Khoo S, Leen C, Lipman M, Manji H, Miller R, Mitchell S, Ong E, Pozniak A, Schmid M, Shiew M, Singer M, Wilkins E, Williams I, Wood C, Weston R, British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011., HIV Medicine, 12 Suppl 2, 2011, p1-140Journal Article, 2011, DOI , URL
  • NĂ­ Cheallaigh C, Fitzgerald I, Grace J, Jagjit Singh G, El-Eraki N, Gibbons N, Keane J, Rogers TR, Clarke S, Bergin C, Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country., PloS one, 8, (1), 2013, pe53330Journal Article, 2013, DOI , TARA - Full Text
  • Kieran J, O'Reilly A, Parker J, Clarke S, Bergin C, Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting., European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 28, (11), 2009, p1369-74Journal Article, 2009
  • Clarke S, Keenan E, Bergin C, Lyons F, Hopkins S, Mulcahy F, The changing epidemiology of HIV infection in injecting drug users in Dublin, Ireland., HIV medicine, 2, (4), 2001, p236-40Journal Article, 2001
  • Clarke S, Keenan E, Ryan M, Barry M, Mulcahy F, Directly observed antiretroviral therapy for injection drug users with HIV infection., The AIDS reader, 12, (7), 2002, p305-7, 312-6Journal Article, 2002
  • Hopkins S, Coleman C, Kelleher M, Keating S, Clarke S, O'Connell B, Mulcahy F, Bergin C, Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoea in Dublin., Irish medical journal, 98, (7), 2005, p208-9Journal Article, 2005
  • Muldoon EG, Mooka B, Reidy D, O'Dea S, Clarke S, Courtney G, Lyons F, Bergin C, Mulcahy F, Long-term neurological follow-up of HIV-positive patients diagnosed with syphilis., International journal of STD & AIDS, 23, (9), 2012, p676-8Journal Article, 2012
  • HPSC, Chlamydia screening in Ireland - A pilot study of opportunistic screening for genital Chlamydia infection in Ireland 2007-2009 , Dublin, 2010Report
  • HPSC, HPSC Subcommittee on Verotoxigenic E coli , HPSC Website, 2010Report
  • HPSC, Report on the Gonorrhoea control group for the HSE Ease and SouthEast HPSC HSE 2016, HPSC Website, 2016Report
  • HPSC, Guidelines on the management of outbreaks of STIs , 2016Report
  • HPSC, SHCPP, GHN, EMIS 2017 Findings from the European MSM Internet Survey (Ireland) , HPSC website and GHN, 2017Report
  • HIV PrEP in Ireland - PrEP estimates for population at risk of sexual acquisition of HIV in Ireland , SHCPP, HPSC, HSE, 2017Report
  • HPSC, EMI Toolkit - Guidelines for the emergency management of injuries and PEP, 2014Report
  • HPSC, C diffsurveillance, diagnosis and management of a disease in Ireland , 2014Report
  • G McHugh, D Kiely, J Low, M L Healy, C Hayes, S Clarke, Importation of Polish trichinellosis cases to Ireland, June 2007, Eurosurveillance, 12, (29), 2007Journal Article
  • The joint investigating team from Scotland, Ireland, and England, Unexplained Illness and Death among injecting-drug users - Glasgow, Scotland: Dublin, Ireland: and England, April-June 2000, MMWR, 2000, p489 - 492Journal Article
  • The joint investigating team from Scotland, Ireland, and England, Update:Clostridium novyi and Unexplained Illness among Injecting Drug Users -- Glasgow, Scotland: Dublin, Ireland: and England, April-June 2000, MMWR, 2000, p543 - 545Journal Article
  • S Clarke, OPAT in SJH - Are we better than the rest?, SJH Grand Rounds, SJH, Dec 2015, 2015Oral Presentation
  • Siobhan O Dea, Mick Quinlan & Susan Clarke & Mick Quinlan, GMHS - Annual reports 2005-2020 , 2020Report
  • Susan Clarke, OPAT in Ireland - the past 5 years, National IRL OPAT Conference, Marker Hotel Dublin, March , 2018, British Society for antimicrobials and chemotherapeutics (BSAC) OPAT subgroupInvited Talk
  • Susan Clarke, OPAT and GPs - everything you need to know, St James's GP Study Day, SJH Trinity Center, 2018, ICGPInvited Talk
  • Susan Clarke, Infectious Complications of Venous Disease, Venous Disease Study Day SJH, Trinity Centre SJH, Nov, 2018, Vascular Dept SJHInvited Talk
  • Susan Clarke, OPAT in Ireland, National UK OPAT Meeting, Birmingham, Nov, 2017, BSAC (British society for antimicrobial agents and chemotherapeutics) - OPAT subgroupInvited Talk
  • Susan Clarke, OPAT Services in Ireland - Measures of Success, RCPI Masterclass in Infectious Diseases, RCPI, Sept, 2015, RCPIInvited Talk
  • Susan Clarke, The Evolution of an OPAT Program in Ireland 2013-2015, National Healthcare Conference, Bord Gais Theatre, 2015Invited Talk
  • Susan Clarke, OPAT Update , Irish National MRSA Reference Laboratory 4th National MRSA Scientific Meeting, RCPI, 2013, Irish Society of Clinical MicrobiologyInvited Talk
  • Susan Clarke, Prevention, Investigation and Management of Infections in IVDUs (non viral), ICGP certif in Substance Misuse and assess Health Problems, 2013Invited Talk
  • Susan Clarke, All GPs need to know about HIV, Hepatitis B and Hepatitis C, ICGP Summer School, Kilkenny, 2013, ICGPInvited Talk
  • Susan Clarke, Optimising the Management of Infections in Drug Users, IOTOD (Improving Outcomes in the treatment of Opioid Dependance), Berlin, 2012, IOTODInvited Talk
  • Susan Clarke, OPAT in Ireland - Where are we now?, Antibiotic Awareness Day, Dublin, 2012, Irish Society of Clinical MicrobiologyInvited Talk
  • Susan Clarke, Missed opportunities to diagnose and strategies to treat, RCPI Masterclass in ID, RCPI, 2011Invited Talk
  • Susan Clarke, Missed Opportunities for a simple test, St Lukes Day RCPI, RCPI, 2011Invited Talk

Research Expertise

Other Clinical Medicine, Immunity and Infection (including Rheumatology & Inflammatory disease), Population Health, Public & Environment Health, Health Care & Health Services (including Health Technology and Health Information Systems),

Recognition

  • HSE Excellence Awards - Innovation in Service Delivery Award - Awarded for the GMHS Nurse-led Asymptomatic clinic initiative. Dec 2017
  • Maxwell Finland award for Excellence in Infectious Diseases Research at the annual Spring meeting of the Massachusetts Infectious Diseases Society. I was nominated for this award by the clinical and research Infectious Diseases faculty at Boston University Medical Centre. 2003
  • Edward H. Kass award for Clinical Excellence, presented by the Massachusetts Infectious Diseases Society. I was nominated for this award also by the clinical and research faculty of Boston University. 2004
  • Travelling scholarship for a clinical presentation at the Spring meeting of the MSSVD - "Directly administered antiretroviral therapy (DAART) for the treatment of HIV infection in drug users". 2000
  • Bristol-Myers-Squibb travelling scholarship at the British HIV Association Spring meeting in Brighton for oral presentations on familial HIV disease, and the role of the multidrug transporter P-gp in HIV disease. 2001
  • Best Oral presentation: British HIV Association meeting in Cambridge - 'The efficacy and tolerability of a programme of directly observed therapy (DOT) for drug users with HIV infection.' 1999
  • Travelling scholarship for an oral presentation at the British HIV Association meeting in Cambridge - 'The efficacy and tolerability of a programme of directly observed therapy (DOT) for drug users with HIV infection.' 1999
  • Ortho Biotech travelling scholarship to the International AIDS Society meeting. This award was presented to ten Infectious Diseases Fellows throughout the United States, after a national competitive process based on clinical case presentations and discussions. 2002
  • British HIV Association (BHIVA) to date
  • Irish Hospital Consultants Association date
  • Fellow of the Royal College of Physicians date
  • Infectious Diseases Society of Ireland date
  • Society for the Study of Sexually transmitted Diseases in Ireland (SSSTDI) to date
  • IDSI Representative on the SH24 Steering/Evaluation Group 2020
  • BMS High Level Teaching sessions to Clinical Colleagues in the Pharmaceutical Industry 2008
  • IDSI Representative - Chlamydia Screening in Ireland - A Pilot Study of Opportunistic Screening for Genital CT infection in Ireland - HPSC, HRB, HSE 2007-2009
  • IDSI Representative on the MSM Health Committee - HPSC, SHCPP 2019
  • IDSI Representative to the Chlamydia Screening in Ireland Pilot Study - RCSI, HRB, NUIG 2012
  • IDSI representative to the HPSC SubCommittee on Verotoxigenic E coli Infection 2010
  • IDSI Representative on the Emergency Management of Injuries (EMI toolkit) HPSC 2014
  • Reviewer for the International Journal of STDs and AIDS 2005
  • IDSI Representative on the group EMIS 2017- Findings for the European MSM Internet Survey (IRL) SHCPP, HSE, GHN, HPSC 2017
  • IDSI Representative on the HIV PrEP in Ireland Group - PrEP estimates for population at risk of sexual acquisition of HIV in Ireland - SHCCP, HPSE, HSE 2017
  • Journal reviewer International Journal of STDs and AIDS 2006
  • IDSI Representative on the C diff Subcommittee - Surveillance, Diagnosis and Management of C diff associated disease in Ireland 2008
  • IDSI Representative on the RCPI Policy Group on Sexual Health 2010
  • Journal Reviewer HIV Medicine 2006
  • European AIDS Clinical Society Meeting (EACS) - Organising committee 2015
  • IDSI Representative on the Report of the Gonorrhoea Control Group for the HSE E and SE, HSE and HPSC 2016
  • National Ireland OPAT Conference - Chair of the organising committee 2017
  • IDSI Representative on the Chemsex Working Group (CWGI) 2018
  • IDSI Representative on the Guidance on Management of Outbreaks of STIs - HSE and HPSC 2016
  • Journal reviewer Irish Medical Journal 2006
  • IDSI Organising Committee since 2005 2005
  • Reviewer for the Irish Medical Journal 2010